143 related articles for article (PubMed ID: 8171214)
1. Prediction and monitoring of the carcinogenicity of polycyclic aromatic compounds (PACs).
Shaw GR; Connell DW
Rev Environ Contam Toxicol; 1994; 135():1-62. PubMed ID: 8171214
[TBL] [Abstract][Full Text] [Related]
2. Molecular dosimetry of DNA damage induced by polycyclic aromatic hydrocarbons; relevance for exposure monitoring and risk assessment.
Baan RA; Steenwinkel MJ; van den Berg PT; Roggeband R; van Delft JH
Hum Exp Toxicol; 1994 Dec; 13(12):880-7. PubMed ID: 7718309
[TBL] [Abstract][Full Text] [Related]
3. Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Carcinogenesis; 1999 Oct; 20(10):1885-91. PubMed ID: 10506100
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
[TBL] [Abstract][Full Text] [Related]
5. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
[TBL] [Abstract][Full Text] [Related]
6. Separation of 32P-postlabeled DNA adducts of polycyclic aromatic hydrocarbons and nitrated polycyclic aromatic hydrocarbons by HPLC.
King LC; George M; Gallagher JE; Lewtas J
Chem Res Toxicol; 1994; 7(4):503-10. PubMed ID: 7526903
[TBL] [Abstract][Full Text] [Related]
7. Alternative pathways of polycyclic aromatic hydrocarbons activation: the formation of polar DNA adducts.
Baer-Dubowska W
Acta Biochim Pol; 1999; 46(2):263-74. PubMed ID: 10547028
[TBL] [Abstract][Full Text] [Related]
8. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses.
Lewtas J; Walsh D; Williams R; Dobiás L
Mutat Res; 1997 Aug; 378(1-2):51-63. PubMed ID: 9288885
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
10. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
Reddy MV; Gupta RC; Randerath E; Randerath K
Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
12. DNA adducts produced by oils, oil fractions and polycyclic aromatic hydrocarbons in relation to repair processes and skin carcinogenesis.
Ingram AJ; Phillips JC; Davies S
J Appl Toxicol; 2000; 20(3):165-74. PubMed ID: 10797468
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice.
Nesnow S; Ross JA; Stoner GD; Mass MJ
Toxicology; 1995 Dec; 105(2-3):403-13. PubMed ID: 8571376
[TBL] [Abstract][Full Text] [Related]
14. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
15. PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms.
Binkova B; Chvatalova I; Lnenickova Z; Milcova A; Tulupova E; Farmer PB; Sram RJ
Mutat Res; 2007 Jul; 620(1-2):49-61. PubMed ID: 17412371
[TBL] [Abstract][Full Text] [Related]
16. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
[TBL] [Abstract][Full Text] [Related]
17. Covalent DNA adducts formed by benzo[c]chrysene in mouse epidermis and by benzo[c]chrysene fjord-region diol epoxides reacted with DNA and polynucleotides.
Giles AS; Seidel A; Phillips DH
Chem Res Toxicol; 1997 Nov; 10(11):1275-84. PubMed ID: 9403182
[TBL] [Abstract][Full Text] [Related]
18. Standardization of the 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts.
Shields PG; Harris CC; Petruzzelli S; Bowman ED; Weston A
Mutagenesis; 1993 Mar; 8(2):121-6. PubMed ID: 8464380
[TBL] [Abstract][Full Text] [Related]
19. Separation and characterization of post-labeled DNA adducts of stereoisomers of benzo[a]pyrene-7,8-diol-9,10-epoxide by immobilized boronate chromatography and HPLC analysis.
Lau HH; Baird WM
Carcinogenesis; 1994 May; 15(5):907-15. PubMed ID: 8200094
[TBL] [Abstract][Full Text] [Related]
20. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers.
Perera FP; Hemminki K; Young TL; Brenner D; Kelly G; Santella RM
Cancer Res; 1988 Apr; 48(8):2288-91. PubMed ID: 3127049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
